Tech Company Financing Transactions

Twist Bioscience Funding Round

On 1/19/2016, Twist Bioscience raised $61 million in Series D funding from Arch Venture Partners, Cormorant Asset Management and Fidelity Management & Research Company.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

455 Mission Bay Blvd South
San Francisco, CA 94158
USA

Phone

Undisclosed

Website

www.twistbioscience.com

Email Address

[email protected]

Overview

At Twist Bioscience (Nasdaq: TWST), our expertise is accelerating science and innovation by leveraging the power of scale. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, including genes, oligonucleotide pools and variant libraries.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Emily Leproust

        

Chief Financial Officer

Solange Glaize

        

Chief Operating Officer

Bill Banyai

        

Chief Technical Officer

Bill Peck

        

VP - Operations

Patrick Weiss

        

VP - Sales

Patrick Finn

        

Browse more venture capital transactions:

Prev: 1/19/2016: Omni-ID venture capital transaction
Next: 1/19/2016: Big Switch Networks venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary